Singhal Himanshu, Premkumar Prasanna S, Chandy Achamma, Kunjummen Aleyamma T, Kamath Mohan S
Reproductive Medicine Unit, Christian Medical College, Vellore, Tamil Nadu, India.
Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India.
J Hum Reprod Sci. 2017 Apr-Jun;10(2):119-123. doi: 10.4103/jhrs.JHRS_113_16.
The aim of the study was to measure patient's satisfaction level and acceptance of conscious sedation as a method of pain relief following transvaginal oocyte retrieval (TVOR) during assisted reproduction technology treatment. We also evaluated the factors that may influence the efficacy of conscious sedation method.
A prospective cross-sectional study.
Prospective study was conducted from October 2015 to January 2016 at a university-level hospital and 100 women were recruited. Variables for analysis included woman age, duration of procedure, number of oocytes retrieved, and transmyometrial passage of the needle. Pain assessment was done by visual analog scale (VAS). Medical complications, and patient satisfaction score [Likert's score and client satisfaction questionnaire (CSQ)] were recorded.
There was a moderate positive correlation between age and pain score on day 1 post-procedure. When the duration of procedure was >12 min, immediate post-procedure pain score was significantly higher compared to those whose procedure where duration was <12 min. There was no correlation between pain score and the number of oocytes retrieved (≤5, 6-15, and ≥16) and transmyometrial passage of needle. The VAS 10-point score immediately post-procedure, after 6 and 24 h post-procedure, and on day of embryo transfer was 2.83 (±1.67), 0.78 (±1.04), 0.39 (±1.09), and 0.14 (±0.58), respectively. The Likert's score was 3.65 (±0.82) and mean CSQ was 27.04 (±3.01). Majority of the women (86%) preferred the same pain relief method for future analgesia. There were no major complications.
Conscious sedation was associated with high satisfaction level and acceptance rate among patients undergoing TVOR.
本研究的目的是测量患者对在辅助生殖技术治疗中经阴道取卵(TVOR)后采用清醒镇静作为一种疼痛缓解方法的满意度和接受度。我们还评估了可能影响清醒镇静方法疗效的因素。
一项前瞻性横断面研究。
2015年10月至2016年1月在一家大学附属医院进行前瞻性研究,招募了100名女性。分析变量包括女性年龄、手术持续时间、取卵数量以及针经肌层穿刺情况。采用视觉模拟评分法(VAS)进行疼痛评估。记录医疗并发症及患者满意度评分[李克特评分和客户满意度问卷(CSQ)]。
术后第1天年龄与疼痛评分之间存在中度正相关。当手术持续时间>12分钟时,术后即刻疼痛评分显著高于手术持续时间<12分钟的患者。疼痛评分与取卵数量(≤5个、6 - 15个和≥16个)以及针经肌层穿刺情况之间无相关性。术后即刻、术后6小时、术后24小时以及胚胎移植日的VAS 10分制评分分别为2.83(±1.67)、0.78(±1.04)、0.39(±1.09)和0.14(±0.58)。李克特评分为3.65(±0.82),平均CSQ为27.04(±3.01)。大多数女性(86%)希望未来镇痛采用相同的疼痛缓解方法。未发生重大并发症。
清醒镇静在接受TVOR的患者中具有较高的满意度和接受率。